2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol
C21H17N7O — CID 135281149
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol
2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol (PubChem CID 135281149) has the molecular formula C21H17N7O and a molecular weight of 383.42 g/mol. Its IUPAC name is 2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol.
Molecular Properties
| Compound Name | 2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol |
|---|---|
| PubChem CID | 135281149 |
| Molecular Formula | C21H17N7O |
| Molecular Weight | 383.42 g/mol |
| Exact Mass | 383.15 |
| IUPAC Name | 2-[(1R)-1-[[6-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)quinazolin-2-yl]amino]ethyl]phenol |
| SMILES | C[C@@H](Nc1ncc2cc(-c3ncnc4[nH]ncc34)ccc2n1)c1ccccc1O |
| InChI | InChI=1S/C21H17N7O/c1-12(15-4-2-3-5-18(15)29)26-21-22-9-14-8-13(6-7-17(14)27-21)19-16-10-25-28-20(16)24-11-23-19/h2-12,29H,1H3,(H,22,26,27)(H,23,24,25,28)/t12-/m1/s1 |
| InChIKey | FDYSKXLSYSHMAP-GFCCVEGCSA-N |
| XLogP | 3.84 |
| TPSA | 112.50 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 383.42 |
| LogP ≤ 5 | 3.84 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135281149 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.